Location History:
- Moskovskaya Obl., RU (2011 - 2015)
- Moskovskaya Oblast, RU (2018)
Company Filing History:
3 out of 832,761 Years Active: 2011-2018
Title: Elena Dudich: Innovator in Cancer Research
Introduction
Elena Dudich is a prominent inventor based in Moskovskaya obl., Russia. She has made significant contributions to the field of oncology through her innovative research and development of therapeutic agents. With a total of 3 patents, her work focuses on reducing cancer cell proliferation and advancing treatment methodologies.
Latest Patents
Elena's latest patents include groundbreaking methods for utilizing recombinant alpha-fetoprotein. The first patent, titled "Method of reducing cancer cell proliferation by administering recombinant alpha-fetoprotein," discloses pharmaceutical and synergistic compositions of human recombinant alpha-fetoprotein expressed in eukaryotic cells. This innovation is aimed at preparing therapeutic agents for use in oncology, immunotherapy, stem cell therapy, and cosmetology, as well as for the diagnosis of cancer and embryogenic pathologies. The second patent, "Recombinant alpha-fetoprotein and compositions thereof," further elaborates on similar pharmaceutical compositions, emphasizing their potential applications in various medical fields.
Career Highlights
Elena Dudich has established herself as a key figure in cancer research. Her dedication to developing effective treatments has positioned her at the forefront of innovation in this critical area of medicine. Her work not only contributes to scientific knowledge but also holds promise for improving patient outcomes in oncology.
Collaborations
Elena collaborates with notable colleagues, including Igor Dudich and Lydia Semenkova. Their combined expertise enhances the research and development efforts in their respective fields.
Conclusion
Elena Dudich's contributions to cancer research through her innovative patents demonstrate her commitment to advancing medical science. Her work has the potential to significantly impact the treatment of cancer and improve the quality of life for patients.